CLINICAL TRIALS PROFILE FOR SUMAVEL DOSEPRO
✉ Email this page to a colleague
All Clinical Trials for sumavel dosepro
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01016834 ↗ | Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine | Completed | Synteract, Inc. | Phase 4 | 2009-11-01 | The purpose of the study is to evaluate the treatment satisfaction of subjects using Sumavel DosePro to treat their moderate to severe migraines. |
NCT01016834 ↗ | Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine | Completed | Zogenix, Inc. | Phase 4 | 2009-11-01 | The purpose of the study is to evaluate the treatment satisfaction of subjects using Sumavel DosePro to treat their moderate to severe migraines. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for sumavel dosepro
Condition Name
Clinical Trial Locations for sumavel dosepro
Trials by Country
Clinical Trial Progress for sumavel dosepro
Clinical Trial Phase
Clinical Trial Sponsors for sumavel dosepro
Sponsor Name